Literature DB >> 11199515

Relative validity effects with either one or two more valid cues in Pavlovian and instrumental conditioning.

R A Murphy1, A G Baker, N Fouquet.   

Abstract

Two experiments investigated the relative validity effect with either 1 or 2 continuously reinforced cues in Wistar rats using appetitive Pavlovian and instrumental preparations. Discrimination training involved 3 compound cues containing a common element (1AX: 1BX: 2CX). In the first true-discrimination group (TD-1), CX was followed by food, but AX and BX were not. In the second true-discrimination group (TD-2), AX and BX but not CX were followed by food. In the third, pseudodiscrimination group (PD), food followed 50% of each compound. Compared with the PD group, there were lower levels of responding to X in Groups TD-1 and TD-2, which did not differ. That is, both TD treatments showed equivalent relative validity effects. There was evidence for a relative validity effect on the context. The Rescorla-Wagner model incorrectly predicts a smaller relative validity effect after the TD-2 than the TD-1 treatment. Comparator theory predicts these results.

Entities:  

Mesh:

Year:  2001        PMID: 11199515

Source DB:  PubMed          Journal:  J Exp Psychol Anim Behav Process        ISSN: 0097-7403


  3 in total

1.  A test of Rescorla and Wagner's (1972) prediction of nonlinear effects in contingency learning.

Authors:  Joaquín Morís; Susana Carnero; Ignacio Loy
Journal:  Learn Behav       Date:  2012-12       Impact factor: 1.986

2.  Roles of context in acquisition of human instrumental learning: Implications for the understanding of the mechanisms underlying context-switch effects.

Authors:  A Matías Gámez; Samuel P León; Juan M Rosas
Journal:  Learn Behav       Date:  2017-09       Impact factor: 1.986

3.  A comparative approach to cue competition with one and two strong predictors.

Authors:  Irina Baetu; A G Baker; Christine Darredeau; Robin A Murphy
Journal:  Learn Behav       Date:  2005-05       Impact factor: 1.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.